About us: Founded in 2007 and based in Victoria, BC, StressMarq Biosciences is a market leader in the development and commercialization of a range of unique fibrilized and oligomeric protein preparations for use in neurodegenerative disease research, including proteins such as alpha synuclein, tau, amyloid beta, SOD1 and TTR.

In addition to our focus on products for neurodegenerative disease research, our diverse portfolio of antibodies, proteins, kits and small molecules are utilized across a range of life sciences including neuroscience, cancer research and cell signaling.

To aid research worldwide, StressMarq products are available through an extensive network of international distributors in over 45 countries.